OrganiGram Holdings Inc (OGI)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $116.93M
Last updated: Nov 17, 2026 at 11:05 AM ET
OrganiGram Holdings Inc (OGI) Valuation Multiples
OrganiGram Holdings (OGI) trades at 0.4x sales and 0.3x book value. Its P/S of 0.4x is below its 5-year median of 1.1x.
Current Multiples
OGI reports in CAD, so earnings multiples appear here only when its per-share earnings can be confirmed.
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | N/A |
| Price to sales | 0.4x |
| Price to book | 0.3x |
| EV/EBITDA | 8.1x |
| PEG | N/A |
| FCF yield | -23.5% |
Historical Medians
Against its 10-year medians, its P/B is 62.5% below 0.8x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 0.4x | 1.1x | N/A |
| P/B | 0.3x | 0.6x | 0.8x |
Valuation History
Over the 6 of the 10 year ends shown that have a P/S, its P/S ranged from 0.9x in 2023 to 43.9x in 2017.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $1.68 | 1.1x | 0.9x |
| 2024 | $1.61 | 1.2x | 0.8x |
| 2023 | $1.31 | 0.9x | 0.5x |
| 2022 | $3.20 | 1.4x | 0.7x |
| 2021 | $7.00 | N/A | 0.4x |
| 2020 | $5.32 | 4.5x | 1.4x |
| 2019 | $9.80 | N/A | N/A |
| 2018 | $14.27 | N/A | 2.4x |
| 2017 | $12.94 | 43.9x | 4.9x |
| 2016 | $8.60 | N/A | 0.8x |
P/E history is shown only for companies that report in US dollars.
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About OGI
Is OGI stock overvalued?
GNG's valuation label for OGI is Undervalued.
What is OGI's price to sales ratio?
OrganiGram Holdings has a price to sales ratio of 0.4x.
OGI pages: Overview, Financials, Valuation, Competitors